Interestingly, MMP-2 and MMP-9 can bind to low-density lipoprotein receptor-related protein 1 (LRP1), activate ERK, inhibit the JNK pathway, facilitate tight adhesion of tumor cells to the stroma, and induce tumor cell invasion into blood vessels and lymphatic vessels (41). The gene discussed is MMP9; the disease is neoplasm.